U.S. federal trademark · Serial No. 97139421
Medical testing services, namely, next generation sequencing tests for diagnosis, prognosis, and treatment of brain cancer and brain tumors; Medical testing services, namely, immunoassays, enzyme-linked immunosorbent (ELISA) assays for disease detection
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.